Concurrent Commercially Supported Lunch Symposium

12:30 pm-1:30 pm Friday, April 27

My Patient's Not an Addict: Why Should I Prescribe Take-Home Naloxone?

As opioid overdose deaths continue to increase year after year, it’s time to look beyond statistics and stereotypes to our patients with chronic pain who need opioid therapy to be able to do activities of daily living. There are many facets to responsible opioid prescribing. Key among them is actively coprescribing naloxone with opioids as a safety precaution in the home for patients at risk of overdose. Numerous government agencies and professional organizations are recommending that clinicians coprescribe take-home naloxone to help rapidly reverse an opioid overdose, should one occur.

During this symposium, the faculty will provide guidance on how to identify patients at risk of an opioid overdose, and start the conversation in a way that overcomes patient resistance to take-home naloxone being part of their treatment plan. In addition, the faculty will offer their best practices when coprescribing naloxone, educating patients and care partners, and creating an opioid emergency plan.

Learning Objectives:

  • Identify patients at risk for an opioid overdose.
  • Initiate the conversation with at-risk patients and care partners around opioid overdose and the need for take-home naloxone.
  • Implement a strategy to create an opioid emergency plan that includes education and coprescribing take-home naloxone for at-risk patients and care partners.

CSS Registration

Register now!

AAPM provided lunch.

This activity is funded by kaleo, Inc.

Faculty:

Jeffrey A. Gudin, MD
Mark A. Kallgren, MD
Anthony W. Mimms, MD